News
ELAB
5.64
+20.00%
0.94
Weekly Report: what happened at ELAB last week (0310-0314)?
Weekly Report · 2d ago
PMGC Holdings Inc trading resumes
TipRanks · 03/10 14:05
PMGC Holdings Inc trading halted, volatility trading pause
TipRanks · 03/10 13:56
Weekly Report: what happened at ELAB last week (0303-0307)?
Weekly Report · 03/10 12:40
PMGC it has schedules a pre-IND meeting with FDA for EL-22
TipRanks · 03/10 12:11
NORTHSTRIVE BIOSCIENCES : SCHEDULED A PRE-IND MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION FOR APRIL 23, 2025
Reuters · 03/10 12:00
NORTHSTRIVE BIOSCIENCES INC. SCHEDULES PRE-IND MEETING WITH FDA FOR EL-22, AN OBESITY THERAPY TARGETING FAT LOSS AND MUSCLE PRESERVATION IN COMBINATION WITH GLP-1
Reuters · 03/10 12:00
Upcoming Stock Splits This Week (March 10 to March 14) – Stay Invested
TipRanks · 03/10 05:02
PMGC Holdings Inc trading halted, news pending
TipRanks · 03/08 00:51
Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings
Benzinga · 03/06 17:48
Dow Tumbles 1%; US Initial Jobless Claims Decline
Benzinga · 03/06 15:17
PMGC Holdings Announces 1-For-7 Reverse Stock Split To Maintain Nasdaq Listing Compliance; Effective At Midnight, Eastern Time, On March 10, 2025
Benzinga · 03/06 14:33
PMGC Holdings announces 1-for-7 reverse stock split to maintain Nasdaq listing compliance
Seeking Alpha · 03/06 14:31
BUZZ-Elevai Labs sinks after announcement of reverse stock split
Reuters · 03/06 14:14
PMGC announces 1-for-7 reverse stock split
TipRanks · 03/06 14:11
*PMGC Holdings Will Effect 1-For-7 Reverse Stk Split >ELAB
Dow Jones · 03/06 14:02
PMGC HOLDINGS INC - TO EFFECT 1-FOR-7 REVERSE STOCK SPLIT ON MARCH 10, 2025
Reuters · 03/06 14:00
ELEVAI Labs Inc. Ends License Agreement with INmune
TipRanks · 03/03 22:31
PMGC HOLDINGS INC - CO AND INMUNE BIO TERMINATE LICENSE AGREEMENT
Reuters · 03/03 22:10
Weekly Report: what happened at ELAB last week (0224-0228)?
Weekly Report · 03/03 12:39
More
Webull provides a variety of real-time ELAB stock news. You can receive the latest news about PMGC Holdings through multiple platforms. This information may help you make smarter investment decisions.
About ELAB
More
PMGC Holdings Inc. is a diversified holding company that manages and grows its portfolio through strategic acquisitions, investments, and development across various industries. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.